These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33991486)

  • 21. CONSORT in China: past development and future direction.
    Song TJ; Leng HF; Zhong LL; Wu TX; Bian ZX
    Trials; 2015 Jun; 16():243. PubMed ID: 26026311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How (in-)complete are study reports?].
    Rakowitz B
    Dtsch Med Wochenschr; 2011 Apr; 136(15):752. PubMed ID: 21488003
    [No Abstract]   [Full Text] [Related]  

  • 23. On the Reporting of Experimental and Control Therapies in Stroke Rehabilitation Trials: A Systematic Review.
    Lohse KR; Pathania A; Wegman R; Boyd LA; Lang CE
    Arch Phys Med Rehabil; 2018 Jul; 99(7):1424-1432. PubMed ID: 29412168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
    Chan S; Bhandari M
    J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TIDieR-PHP: a reporting guideline for population health and policy interventions.
    Campbell M; Katikireddi SV; Hoffmann T; Armstrong R; Waters E; Craig P
    BMJ; 2018 May; 361():k1079. PubMed ID: 29769210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of the TIDieR checklist to improve understanding and replicability of studies in Physical and Rehabilitation Medicine.
    Negrini S
    Eur J Phys Rehabil Med; 2015 Dec; 51(6):667-8. PubMed ID: 26782678
    [No Abstract]   [Full Text] [Related]  

  • 27. Enhancing CONSORT compliance for improved reporting of randomized controlled trials.
    Pandis N; Turpin DL
    Am J Orthod Dentofacial Orthop; 2014 Jan; 145(1):1. PubMed ID: 24373645
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
    Wang F; Schilsky RL; Page D; Califf RM; Cheung K; Wang X; Pang H
    JAMA Netw Open; 2020 Oct; 3(10):e2014661. PubMed ID: 33030549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of reporting of systematic reviews and meta-analyses of surgical randomized clinical trials.
    Yu J; Chen W; Wu P; Li Y
    BJS Open; 2020 Jun; 4(3):535-542. PubMed ID: 32109006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CONSORT-SPI 2018 extension: a new guideline for reporting social and psychological intervention trials.
    Grant S;
    Addiction; 2019 Jan; 114(1):4-8. PubMed ID: 30091280
    [No Abstract]   [Full Text] [Related]  

  • 31. Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review.
    Hussain JA; Bland M; Langan D; Johnson MJ; Currow DC; White IR
    J Clin Epidemiol; 2017 Aug; 88():81-91. PubMed ID: 28532739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The line of 'no difference' is not engraved in stone: the utility of non-inferiority clinical trials.
    Joshi M; Ananth CV
    BJOG; 2014 Jul; 121(8):920-2. PubMed ID: 24958567
    [No Abstract]   [Full Text] [Related]  

  • 33. A Review of CONSORT Guidelines About Comparison Groups With a Focused Discussion on Implications for Rehabilitation Clinical Trials.
    Levack WMM; Engkasan JP; Heinemann AW; Negrini S
    Am J Phys Med Rehabil; 2020 Mar; 99(3):191-197. PubMed ID: 32079896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toward Better Reporting Standards of Patients' Characteristics in Rehabilitation Trials: Applying a New Conceptual Framework to Current Standards.
    Meyer T; Selb M; Kiekens C; Grubišić F; Arienti C; Stucki G; Negrini S
    Am J Phys Med Rehabil; 2020 Mar; 99(3):216-223. PubMed ID: 31860587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The CONSORT statement for cluster randomised trials].
    Campbell MK; Elbourne DR; Altman DG;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():28-31. PubMed ID: 16464424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consolidated Standards of Reporting Trials (CONSORT) extensions covered most types of randomized controlled trials, but the potential workload for authors was high.
    Ghosn L; Boutron I; Ravaud P
    J Clin Epidemiol; 2019 Sep; 113():168-175. PubMed ID: 31153976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Harms of outcome switching in reports of randomised trials: CONSORT perspective.
    Altman DG; Moher D; Schulz KF
    BMJ; 2017 Feb; 356():j396. PubMed ID: 28196813
    [No Abstract]   [Full Text] [Related]  

  • 39. CONSORT-Equity 2017 extension and elaboration for better reporting of health equity in randomised trials.
    Welch VA; Norheim OF; Jull J; Cookson R; Sommerfelt H; Tugwell P;
    BMJ; 2017 Nov; 359():j5085. PubMed ID: 29170161
    [No Abstract]   [Full Text] [Related]  

  • 40. Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?).
    das Nair R; de Groot V; Freeman J
    Mult Scler; 2019 Sep; 25(10):1337-1347. PubMed ID: 31469355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.